500 patients67,039 observations150 daysLIVE

Patient P-03463

Synthetic patientONX-7 · Day 130 · 65–74 · M · baseline S11Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
47%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S11
  2. Day 42 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 102 GI-04 recommendedGI Support Protocol GI-04
  4. Day 103 Patient acceptedStarted GI-04 in the companion
  5. Day 111 No meaningful changeGI Support Protocol GI-04

What changed?

Trajectory began diverging from predicted response on Day 42.

Primary contributors, last 14 days
  • Inflammatory activity-11
  • Treatment adherence-9
  • GI instability-6
  • Nutritional resilience+5
  • Toxicity+5

What helped?

  • GI Support Protocol GI-04Day 102
    Result: no meaningful change
LIFE OS recommendation
Supportive Compound SC-12
58%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 88% showed improvement
  • median effect visible after 6 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
3.4/10
stable · -0.1 vs previous 14 d
Stress level
Daily log
6.4/10
stable · -0.0 vs previous 14 d
Pessimism score
Daily log
5.2/10
stable · -0.1 vs previous 14 d
Sleep quality
Wearable
27.8/100
worsening · -2.6 vs previous 14 d
Libido
Daily log
2.5/10
worsening · -0.3 vs previous 14 d
HRV
Wearable
27 ms
stable · -1.1 vs previous 14 d
Toxicity
Blood
46/100
worsening · +8.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 43 from the failing basin, 45 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 11 similar · onset 3 d · confidence 52%
  • SC-12 Supportive Compound
    89% improved among 9 similar · onset 6 d · confidence 52%
  • NP-02 Dietary Support Protocol
    57% improved among 14 similar · onset 10 d · confidence 52%
  • More protein
    GI -5.4 next day on high-intake days · n 22
Would not help
  • GI-04 GI Support Protocol
    already tried, no meaningful change
  • AD-05 Adherence Support
    only 30% improved among 10 similar
  • Keep fat low
    GI +4.2 next day on high-intake days · n 20
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.4supporter · 95%
  • Dietary fat load
    +4.2detractor · 95%
  • Alcohol
    +2.1no signal · 44%
  • Caffeine
    +1.5no signal · 32%
  • Histamine load
    +0.7no signal · 15%
  • Lactose
    -0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 25/100
    • Daily logFibre intake low in recent food logs
  • Mucosal barrier integrity 50
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 48 and rising
  • Autonomic recovery 45
    • WearableResting HR 80 bpm
    • WearableShort sleep window
  • Inflammatory signalling 40
    • BloodInflammatory load index 46
    • WearableHRV 27 ms, trending down
  • Drug metabolism and exposure 20
    • BloodToxicity index 46
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 1.9 · butyrate capacity 25/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
30 ms
Sleep
5.4 h
Steps
3,552
Resting HR
80 bpm
Daily log: GI score 48, nutritional resilience 44, adherence 70.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0302152%S1557
P-0303148%S16CR-01improved49
P-0338245%S01GI-04improved56
P-0322543%S19GI-04improved50
P-0345141%S0862
P-0328040%S1357
P-0337938%S12GI-04improved51
P-0300437%S0356
P-0316637%S20CR-01improved62
P-0318336%S0354
P-0319136%S19GI-04improved51
P-0322636%S05GI-04improved43